Selenium, iodine, and the relation with Kashin-Beck disease

Nutrition

Volumn 27, Issue 11-12, 2011, Pages 1095-1100

  Yao, Yunfeng ^a   Pei, Fuxing ^a   Kang, Pengde ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Iodine; Kashin Beck disease; Selenium

Indexed keywords

ALPHA TOCOPHEROL; FULVIC ACID; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; INORGANIC SALT; IODINE; IODINE SALT; MYCOTOXIN; SELENIUM; SELENIUM SALT; SODIUM SELENITE; SUPEROXIDE DISMUTASE; THIOREDOXIN REDUCTASE; THYROID PEROXIDASE; THYROXINE; UNCLASSIFIED DRUG;

ARTICULAR CARTILAGE; CARTILAGE CELL; CELL DEATH; ENDEMIC DISEASE; FOOD CONTAMINATION; GROWTH PLATE; HUMAN; HYPOTHYROIDISM; IODINE DEFICIENCY; KASHIN BECK DISEASE; METAPHYSIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW; SELENIUM DEFICIENCY; THYROID HORMONE SYNTHESIS; THYROXINE BLOOD LEVEL;

ANIMALS; ANTIOXIDANTS; CHINA; DIETARY SUPPLEMENTS; HUMANS; IODINE; KASHIN-BECK DISEASE; MODELS, ANIMAL; PREVALENCE; RISK FACTORS; SELENIUM; THYROID GLAND;

ANIMALIA;

EID: 80053452847     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2011.03.002     Document Type: Review

References (83)

1. An Y.H., Jia X.F., Li X.F., He J., Han S.H.B., Zhang H. Geological environment characteristics and etiology research on Kaschin-Beck disease in China. Geol China 2010, 37:563-569.
2. Report of a national survey of Kashin-Beck disease prevalence in 2005. Chin J Endemiol 2006, 25:67-72. National Kashin-Beck Disease Surveillance Group.
3. The monitoring report of Kashin-Beck disease prevalence rate of the whole country in 2003. Chin J Endemiol 2003, 23:147-149. National Kashin-Beck Disease Surveillance Group.
4. Guo X. Diagnostic, clinical and radiological characteristics of Kashin-Beck disease in Shaanxi Province, PR China. Int Orthop 2001, 25:147-150.
5. Yamamuro T. Kashin-Beck disease: a historical overview. Int Orthop 2001, 25:134-137.
6. Mo D.X. KBD cartilage necrosis histopathology and clinical significance. Chin J Endemic 1982, 1:116-120.
7. Chasseur C., Suetens C., Michel V., Mathieu F., Begaux F., Nolard N., Haubruge E. A 4-year study of the mycological aspects of Kashin-Beck disease in Tibet. Int Orthop 2001, 25:154-158.
8. Yang J.B. Etiology of Kashin-Beck disease. Chin J Endemic 1995, 4:201-204.
9. Haubruge E., Chasseur C., Debouck C., Begaux F., Suetens C., Mathieu F., et al. The prevalence of mycotoxins in Kashin-Beck disease. Int Orthop 2001, 25:159-162.
10. Moreno-Reyes R., Suetens C., Mathieu F., Begaux F., Zhu D., Rivera M.T., et al. Kashin-Beck osteoarthropathy in rural Tibet in relation to selenium and iodine status. N Engl J Med 1998, 339:1112-1120.
11. Malaisse F., Mathieu F. Big bone disease. A multidisciplinary approach of KBD in Tibet Autonomous Region. Presse Agronom Gembloux 2008, 15:70-78. (P.R. China).
12. La Grange M., Mathieu F., Begaux F., Durand M.C. Kashin-Beck disease and drinking water in Central Tibet. Int Orthop 2001, 25:167-169.
13. Yang C., Niu C., Bodo M., Gabriel E., Notohm H., Wolf E., Muller P.K. Fulvic acid supplementation and selenium deficiency disturb the structural integrity of mouse skeletal tissue. Biochem J 1993, 289:829-883.
14. Wang J.P., SH H.Y. A preliminary assessment of environmental geology for Kashin-Beck disease in Rantang, Aba. J Sichuan Geol 2005, 125:169-172.
15. Ge X.L., Wu X.S. A primary study on relation of regional geochemistry to endemic diseases in Heilongjiang Province. J Changchun Univ Earth Sci 1995, 25:63-69.
16. Fang W.X., Wu P.X., Hu R.Z.H., Huang Z.H.Y. Environmental se-mo-b deficiency and its possible effects on crops and Keshan-Beck disease (KBD) in the Chousang area, Yao county, Shaanxi province, China. Environ Geochem Health 2003, 25:267-280.
17. Rotruck J.T., Pope A.L., Ganther H.E., Swanson A.B., Hafeman D.G., Hoekstra W.G. Selenium: biochemical role as a component of glutathione peroxidase. Science 1973, 179:588-590.
18. Venardos KM, Perkins A, Headrick J, Kaye DM. Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: a review. Curr Med Chem 2007;14:1539-49.
19. Fulle S., Protasi F., Di Tano G., Pietrangelo T., Beltramin A., Boncompagni S., et al. The contribution of reactive oxygen species to sarcopenia and muscle ageing, Experimental. Gerontology 2004, 39:17-24.
20. Mo D.X., Ding D.X., Wang Z.H.L., Zhang J.J. The research in selenium and Kashin-Beck relationship for 20 years. Prophylaxis Treat Chin Endemiol 1997, 12:18-21.
21. Richard S. A medical mystery in middle China. Science 2009, 324:1378-1381.
22. Guo X., Zhang S.H.Y., Mo D.X. The role of low selenium in the occurrence of Kashin-Beck disease. J Xi'an Med Univ 1992, 4:99-106.
23. Guang L., Xing Q.J. Analysing geography environmental factors about Keshan disease and Kashin-Beck disease. J Shanxi Teachers Univ Nat Sci 2004, 18:81-86.
24. Wang Z.H.W., Li C.H.F., Li L.Q. An epidemiological study on selenium content in grain, drinking water and in hairs of children in endemic area of HeiLongjiang Province. Chin J Endemic 1985, 4:330-333.
25. Zhang B.J., Yang L.S.H., Wang W.Y., Li Y.H., Li H.R. Selenium in environment and its relationship with Kaschin-Beck disease in Rangtang County, Sichuan Province. Prog Geography 2009, 28:886-891.
26. Li SHJ, Yang LSH, Wang WY, Li YH, Li HR, Wang LZH, et al. Study on relation between selenium concentration in drinking water and Kashin-beck disease in Tibet. Chin J Endemiol 2006;25:428-9.
27. Wu H.Y., Ding R.S.H., Zhang Q., Ding Qi Z.H., Yin Z.H.Q. Analysis of natural decreased regularity and corrected factor about Kashin-beck disease in Banma Country. Chin J Endemic 2004, 23:558-559.
28. Li Q., Zhao Z.H.Z. Prevalence state of Kashin-Beck disease in Qinghai Province: a retrospective analysis. Chin J Endemic 2006, 25:675-677.
29. Guo X. Progression and prospect of etiology and pathogenesis of Kashin-Beck disease. J Xi'an Jiaotong Univ Med Sci 2008, 29:481-488.
30. Lv X.Y., Xu G.Y., Liang S.H.T., Zhang B.D., Ma C.H.G., Zhu C.S.H., et al. The report of comprehensive prevention and control of Kashin-Beck disease in Bin County, Shanxi Province. Endemic Dis Bull 2002, 17:62-66.
31. Bai S.H.Q., Guo L.L. Observations on effect of Kashin-Beck disease prevention by supplying selenium for 20 years in JingChuan County, Gansu Province. Endemic Dis Bull 2002, 17:40-42.
32. Bai S.H.Q., Guo L.L. The X-ray observations about the effect on prevention of Kashin-Beck disease by supplement selenium. Endemic Dis Bull 2000, 15:22-23.
33. Ding B.L. X-ray surveillance of Kashin-Beck disease control by seleniferous salt in Linyou County for 4 years. Endemic Dis Bull 1991, 17:17.
34. Deng J.Y., Li D.Y., Cai W., Zhu L., Liang D.H., Gu Y., et al. Analysis on the data of surveillance for KBD and hair selenium level. Chin J Endemic 1999, 18:442-444.
35. Li Q.W., Li J., Zha X.Z.D., Ding Z.Q.P., Ran L.S. The strategies and measures of prevention for Kashin-Beck disease in Tibet Plateau. J Public Health 2003, 19:1363.
36. Li Q.L., Xiao W., Ding Y.F., Zhang T. Analysing the effect of Se-I salt on Kashin-Beck disease by mathematical statistics method. Med Anim Prev 2007, 23:659-660.
37. Gong H.Q., Za X.S.H.Z., Bai M.C.W., Ge S.D.J. The observation about prevention of Kashin-beck disease in Shetongmen County, Tibet. Endemic Dis Bull 2004, 19:61-62.
38. Bai M.C.W., Za X.S.D., Xi R.R.D., Gong H.Q., Zhao S.H.C.H. The investigation on effect of supplement selenium in KBD-affected area of Linzhou and Sangri County, Tibet. Chin J Endemic 2007, 26:710.
39. Li Q., Zhao Z.H.J., Wen H. Effective observation on children KBD: control with three different methods of selenium supplement in guide endemic area, Qinghai. Endemic Dis Bull 2004, 19:62-64.
40. Cao J., Li S., Shi Z., Yue Y., Sun J., Chen J., et al. Articular cartilage metabolism in patients with Kashin-Beck disease: an endemic osteoarthropathy in China. Osteoarthritis Cartilage 2008, 16:680-686.
41. Zhang G.X., Liu J.X., Liu X.H. Re-histopathologic examinations to the lesion bone cartilage or bone marrow in X-ray. Chin J Endemic 1996, 11:217-221.
42. Wang S.J., Guo X., Zuo H., Zhang Y.G., Xu P., Ping Z.G., et al. Chondrocyte apoptosis and expression of Bcl-2, Bax, Fas, and iNOS in articular cartilage in patients with Kashin-Beck disease. J Rheumatol 2006, 33:615-619.
43. Xiong Y.M., Mo X.Y., Zou X.Z., Song R.X., Sun W.Y., Lu W., et al. Association study between polymorphisms in selenoprotein genes and susceptibility to Kashin-Beck disease. Osteoarthritis Cartilage 2010, 18:817-824.
44. Mo D.X. The influence of T-2 toxins, MON and selenium on Chinese miniature pig cartilage. Chin J Control Endemic Dis 1996, 11:130-133.
45. Sasaki S., Iwata H., Ishiguro N., Habuchi O., Miura T. Low-selenium diet, bone, and articular cartilage in rats. Nutrition 1994, 10:538-543.
46. Peng A. The study on free radicals mechanism of Kashin-Beck disease. Chin J Control Endemic Dis 1990, 5:28-31.
47. Suetens C., Moreno-Reyes R., Chasseur C., Mathieu F., Begaux F., Haubruge E., et al. Epidemiological support for a multifactorial aetiology of Kashin-Beck disease in Tibet. Int Orthop 2001, 25:180-187.
48. Liu H.G., Yan H., Zhou L.W., Zhou L., Liu M.N., Yin X.Y. The influence of T-2 toxins on lipid peroxidation metabolic in low selenium low protein rats. Chin J Endemic 2006, 25:344.
49. Mo X.Y., Pen S.H.Q., Yang T.S.H., Zhang S.H.Y. The effect of selenium on metabolic abnormalities of cartilage matrix induced by T-2 toxin in rats. Chin J Endemic 1994, 3:83-85.
50. Yang C., Niu C., Bodo M., Gabriel E., Notbohm H., Wolf E., et al. Fulvic acid supplementation and selenium deficiency disturb the structural integrity of mouse skeletal tissue. An animal model to study the molecular defects of Kashin-Beck disease. Biochem J 1993, 289:829-835.
51. Peng A., Wang W.H., Wang C.X., Wang Z.J., Rui H.F., Wang W.Z., et al. The role of humic substances in drinking water in Kashin-Beck disease in China. Environ Health Perspect 1999, 107:293-296.
52. Li S.Y., Cao J.L., Shi Z.L., Chen J.H., Zhang Z.T., Hughes C.E., et al. Promotion of the articular cartilage proteoglycan degradation by T-2 toxin and selenium protective effect. J Zhejiang Univ Sci B 2008, 9:22-33.
53. Zhang A., Cao J.L., Yang B., Chen J.H., Zhang Z.T., Li S.Y., et al. Effects of moniliformin and selenium on human articular cartilage metabolism and their potential relationships to the pathogenesis of Kashin-Beck disease. J Zhejiang Univ Sci B 2010, 11:200-208.
54. Ma T., Guo J., Wang F. The epidemiology of iodine deficiency diseases in China. Am J Clin Nutr 1993, 957:264S-266S.
55. Moreno-Reyes R., Suetens C., Mathieu F., Begaux F., Zhu D., Rivers M.T., et al. Kashin-Beck osteoarthropathy in rural Tibet in relation to selenium and iodine status. N Engl J Med 1998, 339:1112-1120.
56. Zimmermann M.B., Jooste P.L., Pandav C.S. Iodine-deficiency disorders. Lancet 2008, 372:1251-1262.
57. Li Q., Zhao Z.H.J., Zhang Q., Wen H., An Y.Q., Liu X.R., et al. The monitoring report of Kashin-Beck disease prevalence and selenium and iodine detection in Qinhai Province in 2003. Chin J Endemic 2004, 23:616.
58. Xu J.M., Wu M.L., Cheng J.H., Zhou X.G., Wang Q.D., Wang J., et al. Study on the relations between Kashin-Beck disease and iodine. Endemic Dis Bull 1999, 14:36-38.
59. Moreno-Reyes R., Suetens C., Mathieu F., Begaux F., Zhu D., Rivera T., et al. Kashin-Beck disease and iodine deficiency in Tibet. Int Orthop 2001, 25:164-166.
60. Zhang W.H., Neve J., Xu J.P., Vanderpas J., Wang Z.L. Selenium, iodine and fungal contamination in Yulin District (People's Republic of China) endemic for Kashin-Beck disease. Int Orthop 2001, 25:188-190.
61. Moreno-Reyes R., Mathieu F., Boelaert M., Begaux F., Suetens C., Rivera M.T., et al. Selenium and iodine supplementation of rural Tibetan children affected by Kashin-Beck osteoarthropathy. Am J Clin Nutr 2003, 78:137-144.
62. Guo R.L., Wang B.L., Zheng H., Zuo A.J., Liang D.C.H., Zhang J.Y. Pathological investigation of bone development retardation caused by iodine deficiency. Chin J Endemic 2005, 24:32-35.
63. Guo R.L., Wang B.L., Zheng H., Zuo A.J., Liang D.C.H., Zhang J.Y. Impairment of bone development in iodine-deficient rats. Chin J Endocrinol Metab 2004, 20:248-250.
64. Wexler J.A., Sharretts J. Thyroid and bone. Endocrinol Metab Clin North Am 2007, 36:673-705.
65. Winkler R., Griebenow S., Wonisch W. Effect of iodide on total antioxidant status of human serum. Cell Biochem Funct 2000, 18:143-146.
66. 2-generating system modulates protein iodination and the activity of the pentose phosphate pathway in dog thyroid. Endocrinology 1991, 128:779-785.
67. Gerard A.C., Many M.C., Daumerie C., Knoops B., Colin I.M. Peroxiredoxin 5 expression in the human thyroid gland. Thyroid 2005, 15:205-209.
68. Kim H., Lee T.H., Park E.S., Suh J.M., Park S.J., Chung H.K., et al. Role of peroxiredoxins in regulating intracellular hydrogen peroxide and hydrogen peroxide-induced apoptosis in thyroid cells. J Biol Chem 2000, 275:18266-18270.
69. Yuan T., Huang J.G., Xia T. The joint action effects of iodine deficiency and smoke inhalation on antioxidation ability of rats. J Environ Health 2000, 17:332-335.
70. Li Y., Wang D.N., Li X.J. Effect of iodine deficiency and excess on the morphology and antioxidizing ability of rat thyroid. Chin J Endemic 2002, 21:91-93.
71. Morand S., Chaaraoui M., Kaniewski J., Dème D., Ohayon R., Noel-Hudson M.S., et al. Effect of iodide on nicotinamide adenine dinucleotide phosphate oxidase activity and duox2 protein expression in isolated porcine thyroid follicles. Endocrinology 2008, 144:1241-1248.
72. Winkler R., Griebenow S., Wonisch W. Effect of iodide on total antioxidant status of human serum. Cell Biochem Funct 2000, 18:143-146.
73. Tatzber F., Griebenow S., Wonisch W., Winkler R. Dual method for the determination of peroxidase activity and total peroxides-iodide leads to a significant increase of peroxidase activity in human sera. Anal Biochem 2003, 316:147-153.
74. Beckett G.J., Arthur J.R. Selenium and endocrine systems. J Endocrinol 2005, 184:455-465.
75. Köhrle J., Jakob F., Contempré B., Dumont J.E. Selenium, the thyroid, and the endocrine system. Endocr Rev 2007, 26:944-984.
76. Giray B., Arnaud J., Sayek I., Favier A., Hincal F. Trace elements status in multinodular goiter. Trace Elem Med Biol 2010, 24:106-110.
77. Köhrle J., Gärtner R. Selenium and thyroid. Best Pract Res Clin Endocrinol Metab 2009, 23:815-827.
78. Aydin K., Kendirci M., Kurtoglu S., Karakucuk E.I., Kiris A. Iodine and selenium deficiency in school-children in an endemic goiter area in Turkey. J Pediatr Endocrinol Metab 2002, 15:1027-1031.
79. Giray B., Hincal F., Tezic T., Okten A., Gedik Y. Status of selenium and antioxidant enzymes of goitrous children is lower than healthy controls and nongoitrous children with high iodine deficiency. Biol Trace Elem Res 2001, 82:35-52.
80. Corvilain B., Contempré B., Longombé A.O., Goyens P., Gervy-Decoster C., Lamy F., et al. Selenium and the thyroid: how the relationship was established. Am J Clin Nutr 1993, 57(2 suppl):244S-248S.
81. Ren F.L., Guo X., Zhang R.J., Wang S.J., Zuo H., Zhang Z.T., et al. Effects of selenium and iodine deficiency on bone, cartilage growth plate and chondrocyte differentiation in two generations of rats. Osteoarthritis Cartilage 2007, 15:1171-1177.
82. Contempre B., Dumont J.E., Denef J.F., Many M.C. Effects of selenium deficiency on thyroid necrosis, fibrosis and proliferation: a possible role in myxoedematous cretinism. Eur J Endocrinol 1995, 133:99-109.
83. Shi X.W., Guo X., Ren F.L., Li J., Wu X.M. The effect of short tandem repeat loci and low selenium levels on endemic osteoarthritis in China. J Bone Joint Surg [Am] 2010, 92:72-80.